Membrane potential studies of Saccharomyces cerevisiae during cider fermentation.
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to B Jarvis.
Explore the source record for details and available documents.
Treatment of cardiac sarcoplasmic reticulum with the crosslinking reagent dithiobis (succinimidyl propionate) in the presence of 125I-calmodulin, resulted in the formation of a 40,000-dalton affinity labeled component, consisting of a 1:1, phospholamban: 125I-calmodulin complex. In parallel experiments, sarcoplasmic reticulum was phosphorylated in the presence of calmodulin and [gamma-32P]ATP, and then treated with the crosslinking reagent to produce an affinity labeled component consisting of a 1:1, calmodulin: 32P-phospholamban complex. These experiments permitted determination of the amount of 125I and 32P incorporated into the 40,000-dalton complexes, as well as the amount of 32P incorporated into the 23,000-dalton form of phospholamban. If 1 mol of Ca2+-dependent ATPase phosphoprotein represents 1 mol of 100,000-dalton Ca2+-dependent ATPase monomer, then there are 4.88 +/- 1.33 mol Ca2+-dependent ATPase/mol of phospholamban. If there are 2 mol of Ca2+-dependent ATPase phosphoprotein/mol of 100,000-dalton Ca2+-dependent ATPase monomer, then there are 9.76 +/- 2.66 mol Ca2+-dependent ATPase/mol phospholamban.
The covalent attachment of 125I-calmodulin to canine cardiac sarcolemma has been achieved using the crosslinker dithiobis(succinimidyl propionate). Sodium dodecyl sulfate-polyacrylamide gel electrophoresis of the crosslinked products revealed three 125I-calmodulin-labeled components of Mr = 125,000, 108,000 and 81,000. That the formation of these three components was Ca-dependent and inhibited by unlabeled calmodulin, or calmodulin antagonists, would indicate that the formation of these components was calmodulin-specific. The size of these 125I-labeled components was unchanged over a range of crosslinker or 125I-calmodulin concentrations indicating that they represent 1:1 complexes between 125I-calmodulin (Mr = 17,000) and Mr = 108,000, 91,000 and 64,000 sarcolemma components respectively. The labeling of these components with 125I-calmodulin was not enhanced when endogenous calmodulin was removed from sarcolemma. The possible identity of the 125I-calmodulin-labeled sarcolemma components is discussed.
Explore the source record for details and available documents.
R24571 a derivative of the antimycotic miconazole, appears to be 5 to 8 times more potent than trifluoperazine in its ability to inhibit the calmodulin-dependent phosphorylation of cardiac sarcoplasmic reticulum vesicles. The cAMP-dependent protein kinase mediated phosphorylation of cardiac sarcoplasmic reticulum was not affected by R24571. Sarcoplasmic reticulum Ca-dependent ATPase phosphoprotein intermediate formation was inhibited by R24571 concentrations that were 20 to 30 times greater than those required to inhibit calmodulin-dependent phosphorylation. However, both Ca-dependent and independent ATPase activities, as well as calcium uptake, were inhibited by R24571 concentrations that were similar to, or less than, those concentrations required to inhibit calmodulin-dependent sarcoplasmic reticulum phosphorylation. These results indicate the caution that should be exercised in using this new compound in assessing the possible involvement of calmodulin in other membrane processes.
This paper considers the technical problems associated with the quantitative analysis of mould in foods and feedingstuffs. It seeks to define a philosophy concerning the use of quantitative mycological data in advisory, investigatory and quality assurance situations and stresses the need for quantitative estimates always to be aligned with qualitative assessment of the mycoflora of foods and feedingstuffs.
Letter-stimuli as targets were presented to the right or left visual fields and followed either by a flash of light or by a flash of light plus a patterned mask. The patterned mask always appeared in the opposite visual field of the letter targets. Analysis showed that masking occurred for both types of masks but that subjects produced more errors at each of five intervals between onset of the target and onset of the mask for the flash of light plus a patterned mask in the opposite visual field than for the flash of light alone. A pattern mask, when presented to the opposite visual field of a target stimulus, interferes with target processing at short target-mask intervals. These findings suggest that central backward masking may involve target-mask interactions beyond the visual cortex (Area 17).
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Phospholamban, a 23,000-dalton phosphoprotein present in cardiac muscle sarcoplasmic reticulum vesicles is quantitatively dissociated into three smaller sized phosphorylated components of 11,000, 15,000, and 20,000 daltons when sarcoplasmic reticulum, solubilized in 1% (w/v) sodium dodecyl sulfate and 1 mM MgCl2, is heated at 71 degrees C or greater for 2 min. This dissociation is inhibited by Mg2+ (50% at approximately 5 mM). The 23,000-dalton phosphoprotein reformed from the 11,000-, 15,000-, and 20,000-dalton phosphorylated components when phosphorylated sarcoplasmic reticulum that had been boiled in 1% sodium dodecyl sulfate and 1 MM MgCl2 was stored for 1 week at -70 degrees C. We propose that the 23,000-dalton phosphorylated protein is a trimer, composed of three subunits with molecular mass of 11,000, 8,000, and 4,000 daltons. In this model, only the 11,000-dalton subunit would be phosphorylated. The partial dissociation of the 23,000-dalton phosphorylated protein would result in the formation of the 19,000 (11,000 + 8,000)-dalton or the 15,000 (11,000 + 4,000)- dalton phosphorylated components. Full dissociation of the 23,000-dalton phosphorylated protein would result in the formation of the 11,000-dalton phosphorylated component.
Canine cardiac sarcoplasmic reticulum vesicles have been labeled by covalent cross-linking to membrane-bound 125I-calmodulin with dithiobis(succinimidyl propionate). Electrophoretic analysis in sodium dodecyl sulfate demonstrated a 125I-containing major product of Mr = 40,000, and a minor component of Mr = 120,000. This latter component probably represents a 1:1 complex between the 100,000-dalton Ca2+-ATPase protein and 125I-calmodulin. When cross-linked samples, solubilized in sodium dodecyl sulfate, were boiled for 2 min, the radioactivity associated with the 40,000-dalton component decreased while that associated with components of 26,000 and 28,000 daltons increased. When these boiled samples were stored at -70 degrees C for 1 week, the radioactivity associated with the 26,000- and 28,000-dalton components decreased whereas that associated with the 40,000-dalton component was increased. This suggests that the 40,000-dalton component represents a 1:1 cross-link between the 23,000-dalton form of phospholamban and 125I-calmodulin. The 26,000- and 28,000-dalton cross-linked components probably represent 1:1 cross-links between 125I-calmodulin and the 8,000- and 11,000-dalton subunits, respectively, of phospholamban. A 32P-containing, 40,000-dalton component was formed when dithiobis(succinimidyl propionate) was added to sarcoplasmic reticulum vesicles, phosphorylated in the presence of [gamma-32P]ATP and 3 microM calmodulin. This confirms that the 40,000-dalton affinity-labeled component is a 1:1 cross-link between phospholamban and calmodulin. We propose that phospholamban is the endogenous receptor for calmodulin in cardiac sarcoplasmic reticulum membranes. However, it is unlikely that phospholamban is the endogenous calmodulin-dependent protein kinase in this membrane.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.